Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

ClinicalTrials.gov ID: NCT04923464

Public ClinicalTrials.gov record NCT04923464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Decentralized Pilot Study With Wearable Technology in Cystic Fibrosis Subjects 18 Years of Age and Older Taking Commercial Elexacaftor/Tezacaftor/Ivacaftor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the performance of wearable technology in cystic fibrosis (CF) participants taking commercial Elexacaftor (ELX)/Tezacaftor (TEZ)/Ivacaftor (IVA) utilizing a fully decentralized trial design.

Study identification

NCT ID
NCT04923464
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
51 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2021 (Actual)
Primary completion
Dec 20, 2021 (Actual)
Completion
Dec 20, 2021 (Actual)
Last update posted
Jan 19, 2022

2021

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
National Jewish Health Denver Colorado 80206 —
Yale New Haven Hospital New Haven Connecticut 06510 —
Central Florida Pulmonary Group, P.A. Orlando Florida 32803 —
Children's Hospital of Illinois at OSF Saint Francis Medical Center, Cystic Fibrosis Center Peoria Illinois 61637 —
Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center Boston Massachusetts 02114 —
Washington University School of Medicine St Louis Missouri 63110 —
Morristown Medical Center Morristown New Jersey 07960 —
Mount Sinai Beth Israel New York New York 10003 —
Santiago Reyes, M.D. Oklahoma City Oklahoma 73112 —
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
UW School of Medicine & Public Health Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04923464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04923464 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →